DNA is chemically modified in ways that change how genes are read without altering the underlying sequence. DNA methylation is the addition of a methyl group to cytosine bases, typically where cytosine precedes guanine (CpG sites). This modification is a central mechanism of epigenetic regulation described by Andrew P. Feinberg of Johns Hopkins School of Medicine and others as a stable mark that helps determine which genes are active in a given cell type. Methylation patterns are cell-type specific and can be maintained through cell divisions, so they carry regulatory information across time.
Molecular mechanisms
Methyl groups at CpG sites influence gene activity through at least two molecular routes. First, methylation can block transcription factor binding directly when the chemical change alters DNA recognition. Second, methylated DNA is recognized by proteins such as methyl-CpG-binding domain proteins described by Adrian Bird at the University of Edinburgh, which recruit chromatin-modifying complexes. Those complexes add or remove histone marks and change chromatin compaction, converting DNA into a form that is less accessible to the transcriptional machinery. DNA methyltransferases that install the marks and ten-eleven translocation enzymes that oxidize and remove them together create a dynamic equilibrium; researchers including Wolf Reik at the Babraham Institute have documented how these enzymes reshape methylation during early development and germline reprogramming.
Developmental and environmental causes
Patterns of methylation are established during embryogenesis and further shaped by life experience. Work by Michael Meaney at McGill University and Moshe Szyf at McGill University showed that early maternal care can alter methylation at stress-related genes, producing persistent changes in gene expression and behavior. Nutritional inputs that affect one-carbon metabolism provide the methyl donor S-adenosylmethionine, and classic experiments by Robert Waterland at Baylor College of Medicine with the agouti mouse demonstrate how maternal diet shifts offspring methylation and phenotype. Environmental exposures such as tobacco smoke, air pollutants, and certain chemicals are associated in population studies with altered methylation at specific loci, a plausible pathway linking environment to disease risk. Not every exposure produces uniform changes; responses vary with dose, timing, and the genetic and social context of individuals and communities.
Consequences and clinical relevance
Functionally, methylation contributes to processes such as X-chromosome inactivation, genomic imprinting, and suppression of transposable elements, thereby protecting genome stability and ensuring correct developmental programs. Aberrant methylation patterns are hallmarks of many cancers, where tumor suppressor genes may become hypermethylated and silenced, a phenomenon characterized by researchers including Stephen B. Baylin at Johns Hopkins School of Medicine and Manel Esteller at Bellvitge Biomedical Research Institute. Clinically, inhibitors of DNA methyltransferases are used to reverse pathogenic hypermethylation in certain hematologic malignancies, illustrating the therapeutic relevance of this epigenetic mark. At a societal level, because methylation mediates interactions between environment and gene regulation, it contributes to health disparities when environmental burdens concentrate in particular territories or populations. Understanding methylation therefore bridges molecular biology, public health, and social context, offering targets for intervention while reminding us that gene regulation is shaped by both biology and lived experience.